期刊文献+

共刺激分子对全身炎症反应综合征中细胞因子的影响 被引量:1

The Effects of Co-stimulatory Molecules on the Expression of Cytokines in Systemic Inflammatory Response Syndrome
原文传递
导出
摘要 目的:探讨全身炎症反应综合征(SIRS)中相关共刺激分子的表达及其调控因素,并对共刺激分子在全身炎症反应综合征发展及治疗中的作用及机制进行初步探究。方法:腹腔注射脂多糖(LPS)建立全身炎症反应综合征的小鼠动物模型后,将BALB/c模型小鼠随机分为生理盐水(NS)、LPS、CD28+LPS三组,进行脾淋巴细胞的分离,通过RT-PCR、ELISA等方法检测共刺激分子在不同组别中的表达。结果:经CD28活化型单克隆抗体(CD28mAb)刺激后的BALB/c小鼠组中共刺激分子CD40配体(CD40L)、杀伤性T细胞相关抗原-4(CTLA-4)的表达量较生理盐水组明显增高。结论:共刺激分子CD28对于全身炎症反应综合征有促进的作用。 Objective: To investigate the expression level of co-stimulatory molecules in mouse model of systemic inflammatory response syndrome (SIRS), and try to find out the primary mechanism and effect of co-stimulator cytokines in SIRS. Methods: By injecting lipopolysaccharide (LPS), the mouse model of SIRS was established successfully. BALB/c mice were divided into 3 groups at random, and were treated with normal saline(NS), LPS, CD28mAb+LPS. Enzyme linked immunosorbent assay (ELISA) was used to measure IL-6 and some other cytokines in serum, such as CD40 ligand (CD40L) and Cytotoxic T lymphocyte associated antigen-4 (CTLA-4). Spleen lymphocytes were separated to detect cytokines and co-stimulatory molecules by RT-PCR. Results: We find the positive control group with SIRS highly expresses inflammatory related cytokines and co- stimulatory molecules. For the BALB/c of injecting activated CD28mAb group, the expression of CD40L was up-regulated while CTLA-4 was down-regulated. Conclusions: CD28 as a co-stimulatory molecule plays an important role in increasing inflammatory response degree in SIRS.
出处 《现代生物医学进展》 CAS 2009年第7期1217-1219,共3页 Progress in Modern Biomedicine
基金 国家自然科学基金(NO.30771995 NO.30671962) 北京大学医学部创新人才培养计划资助项目(C06012)。
关键词 全身炎症反应综合征 共刺激分子 CD28 CD28mAb SIRS Co-stimulatory molecules CD28 CD28mAb
  • 相关文献

参考文献13

  • 1Ward PA. The dark side of C5a in sepsis [J]. Nat Rev Immunol, 2004, 4(2): 133-142
  • 2Chen Zhen-juan, Ruan Bing. Progress about molecular mechanism and treatment of systemic inflammatory response syndrome [J]. Inter J Epidemiol Infect Dis, 2007, 34 (6):402-404
  • 3Matsuda N, Hattori Y. Systemic inflammatory response syndrome (SIRS): molecular pathophysiology and gene therapy[J]. J Pharmacol Sci, 2006, 101(3):189-198
  • 4Hamann L, Schumann RR, Flad HD, et al. Binding of lipopoysaccharide (LPS) to CHO ceils does not correlate with LPS-induced NF-K b activation [J]. Eur J Immunol, 2000, 30(1):211-216
  • 5Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) [J]. Ann Intern Med, 1996, 125(8): 680 - 681
  • 6Levy MM, Fink MP, Marshall JC, et al .2001 SCCM/ ESICM/ ACCP/ATS/SIS international sepsis definitions conference [J]. Intensive Care Med, 2003, 29(4): 530-538.
  • 7Nathens AB, Marshall JC. Sepsis, SIRS, and MODS: What is in a name [J].World J Surg, 1996, 20:386 -388.
  • 8Cavillon Jm, Adib Cm, Fitting C, et al. Cytokine cascade in Sepsis [J]. Scand J Infect Dis, 2003, 35(9) :535- 544.
  • 9Chambers CA, Allsion JP. Co-stimulation in T cell responses [J]. Curr Opin Immunol, 1997, 9(3):396-404
  • 10Lenschow Dj, Walnuas T1, Bluestone JA. CD28/B7 system of T cell costimulation [J]. Annu Rev Immunol, 1996, 14:233 - 258

同被引文献18

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部